Annual Total Long Term Liabilities
$0.00
-$8.20 M-100.00%
31 December 2023
Summary:
Seelos Therapeutics annual total long term liabilities is currently $0.00, with the most recent change of -$8.20 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$7.49 million (-100.00%). SEEL annual total long term liabilities is now -100.00% below its all-time high of $17.89 million, reached on 31 December 2021.SEEL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 June 2024
Summary:
Seelos Therapeutics quarterly total long term liabilities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has dropped by -$1.30 million (-100.00%). SEEL quarterly long term liabilities is now -100.00% below its all-time high of $17.89 million, reached on 31 December 2021.SEEL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | -100.0% | -100.0% |
SEEL Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Seelos Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $1.30 M(-55.9%) |
| June 2023 | - | $2.96 M(-42.0%) |
| Mar 2023 | - | $5.10 M(-37.8%) |
| Dec 2022 | $8.20 M(-54.2%) | $8.20 M(-23.7%) |
| Sept 2022 | - | $10.74 M(-9.1%) |
| June 2022 | - | $11.81 M(-20.9%) |
| Mar 2022 | - | $14.93 M(-16.6%) |
| Dec 2021 | $17.89 M(+138.8%) | $17.89 M(>+9900.0%) |
| Sept 2021 | - | $0.00(-100.0%) |
| June 2021 | - | $16.00 K(-99.5%) |
| Mar 2021 | - | $3.27 M(-56.3%) |
| Dec 2020 | $7.49 M(+2205.5%) | $7.49 M(+2059.4%) |
| Sept 2020 | - | $347.00 K(0.0%) |
| June 2020 | - | $347.00 K(+73.5%) |
| Mar 2020 | - | $200.00 K(-38.5%) |
| Dec 2019 | $325.00 K(+1931.3%) | $325.00 K(0.0%) |
| Sept 2019 | - | $325.00 K(>+9900.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $16.00 K(-97.9%) | $16.00 K(-38.5%) |
| Sept 2018 | - | $26.00 K(-25.7%) |
| June 2018 | - | $35.00 K(-16.7%) |
| Mar 2018 | - | $42.00 K(-94.4%) |
| Dec 2017 | $752.00 K(-18.4%) | $752.00 K(+9.0%) |
| Sept 2017 | - | $690.00 K(+72.9%) |
| June 2017 | - | $399.00 K(-79.2%) |
| Mar 2017 | - | $1.92 M(+108.4%) |
| Dec 2016 | $922.00 K(-54.8%) | $922.00 K(-72.4%) |
| Sept 2016 | - | $3.34 M(+42.7%) |
| June 2016 | - | $2.34 M(-41.8%) |
| Mar 2016 | - | $4.03 M(+97.3%) |
| Dec 2015 | $2.04 M(-65.9%) | $2.04 M(-80.8%) |
| Sept 2015 | - | $10.66 M(+10.2%) |
| June 2015 | - | $9.67 M(-10.6%) |
| Mar 2015 | - | $10.81 M(+80.6%) |
| Dec 2014 | $5.98 M(+935.3%) | $5.98 M(+323.2%) |
| Sept 2014 | - | $1.41 M(-3.7%) |
| June 2014 | - | $1.47 M(-3.6%) |
| Mar 2014 | - | $1.52 M(+163.7%) |
| Dec 2013 | $578.00 K(-91.1%) | $578.00 K(-70.4%) |
| Sept 2013 | - | $1.95 M(-22.7%) |
| June 2013 | - | $2.53 M(-64.2%) |
| Mar 2013 | - | $7.07 M(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $6.49 M(+265.3%) | $6.49 M(+167.0%) |
| Sept 2012 | - | $2.43 M(+63.8%) |
| June 2012 | - | $1.49 M(-17.9%) |
| Mar 2012 | - | $1.81 M(+1.8%) |
| Dec 2011 | $1.78 M(-64.3%) | $1.78 M(-63.1%) |
| Sept 2011 | - | $4.82 M(-0.4%) |
| June 2011 | - | $4.84 M(-2.4%) |
| Mar 2011 | - | $4.96 M(-0.5%) |
| Dec 2010 | $4.98 M(+22.9%) | $4.98 M(-0.4%) |
| Sept 2010 | - | $5.00 M(-0.4%) |
| June 2010 | - | $5.02 M(-0.5%) |
| Mar 2010 | - | $5.04 M(+24.5%) |
| Dec 2009 | $4.05 M(-28.0%) | $4.05 M(-11.1%) |
| Sept 2009 | - | $4.56 M(-14.4%) |
| June 2009 | - | $5.33 M(-6.5%) |
| Mar 2009 | - | $5.70 M(+1.3%) |
| Dec 2008 | $5.63 M(+59.0%) | $5.63 M(-1.3%) |
| Sept 2008 | - | $5.70 M(-0.3%) |
| June 2008 | - | $5.72 M(+58.9%) |
| Mar 2008 | - | $3.60 M(+1.7%) |
| Dec 2007 | $3.54 M(+234.4%) | $3.54 M(+247.8%) |
| Sept 2007 | - | $1.02 M(+0.4%) |
| June 2007 | - | $1.01 M(-0.3%) |
| Mar 2007 | - | $1.02 M(-3.9%) |
| Dec 2006 | $1.06 M(-77.9%) | $1.06 M(-1.6%) |
| Sept 2006 | - | $1.07 M(-1.3%) |
| June 2006 | - | $1.09 M(-74.2%) |
| Mar 2006 | - | $4.23 M(-11.8%) |
| Dec 2005 | $4.79 M(-29.6%) | $4.79 M(-45.2%) |
| Sept 2005 | - | $8.74 M(-12.0%) |
| June 2005 | - | $9.93 M(+48.3%) |
| Mar 2005 | - | $6.70 M(-1.5%) |
| Dec 2004 | $6.80 M(-7.3%) | $6.80 M(-0.5%) |
| Sept 2004 | - | $6.83 M(-2.2%) |
| June 2004 | - | $6.99 M(-2.3%) |
| Mar 2004 | - | $7.15 M(-2.6%) |
| Dec 2003 | $7.34 M(+35.0%) | $7.34 M(+224.8%) |
| Sept 2003 | - | $2.26 M(-28.5%) |
| June 2003 | - | $3.16 M(-22.5%) |
| Mar 2003 | - | $4.08 M(-24.9%) |
| Dec 2002 | $5.43 M(+649.7%) | $5.43 M(+3.2%) |
| Sept 2002 | - | $5.26 M(+3.6%) |
| June 2002 | - | $5.08 M(+683.7%) |
| Mar 2002 | - | $648.20 K(-10.5%) |
| Dec 2001 | $724.60 K(>+9900.0%) | $724.60 K(+19.9%) |
| Sept 2001 | - | $604.10 K |
| Dec 1997 | $0.00 | - |
FAQ
- What is Seelos Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics annual total long term liabilities year-on-year change?
- What is Seelos Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly long term liabilities year-on-year change?
What is Seelos Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SEEL is $0.00
What is the all time high annual total long term liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total long term liabilities is $17.89 M
What is Seelos Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SEEL annual total long term liabilities has changed by -$8.20 M (-100.00%)
What is Seelos Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SEEL is $0.00
What is the all time high quarterly long term liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total long term liabilities is $17.89 M
What is Seelos Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SEEL quarterly total long term liabilities has changed by -$1.30 M (-100.00%)